My 8-Min Guideline Towards BMN 673

Results:? The mean follow-up period pre- and post-trabeculectomy was 3.9?years (min 0.9, max 10.7) and 3.8?years (min 2.0, max 8.0), respectively. The intraocular pressure (IOP) decreased from 18.1?mmHg (SD?=?4.7) before trabeculectomy to 11.1?mmHg (SD?=?2.9) at the last follow-up after trabeculectomy. The rate of MD loss was reduced with 56% on average, from ?0.36?dB/year http://www.selleckchem.com/products/bmn-673.html before surgery to ?0.16?dB/year after surgery (p?=?0.15). Conclusion:? Trabeculectomy considerably decreased the rates of change in the glaucomatous visual field. ""Purpose:? To analyse the frequency of neuromyelitis optica (NMO) among consecutive optic neuritis (ON) patients in Southern Finland and the feasibility of Aquaporin-4 (AQP4) autoantibody assay in the diagnosis of NMO. Methods:? Consecutive patients with symptoms suggestive of acute ON and managed in the Helsinki University Central Hospital were evaluated critically screened for AQP4 autoantibody during a 47.5-month period. The antibodies were determined http://www.selleckchem.com/products/pexidartinib-plx3397.html using radioimmunoprecipitation method. AQP4 index >15 was considered positive, 10�C15 borderline and http://www.selleck.cn/products/nlg919.html lesions in MRI, which is a risk factor for developing MS. Two patients (1.1%; 95% CI 0.3�C4.5) fulfilled the criteria of NMO. Positive AQP4 antibodies were found in three patients (1.6% 95% CI 0.3�C4.5), one of them had NMO, one had MS and one became diagnosed with MS a month later. Borderline autoantibody levels were found in 10 patients, 7 of whom had MS. Conclusions:? NMO is rare among ON patients in the population of Southern Finland. In this small cohort, the sensitivity and positive predictive values of the AQP4 autoantibody index for NMO were low, 1/2 and 1/3 respectively, and do not support initiating routine screening. ""Purpose:? To report our experiences during the transition from penetrating keratoplasty to Descemet��s stripping with endothelial keratoplasty (DSEK). Methods:? All patients undergoing DSEK during the period of April 2008 to April 2009 were included in this study. Results:? All grafts were attached and clear at both the 6- and 12?-month follow-up examinations. Mean best-corrected visual acuity was 0.6 at 6?months and 0.7 at 12?months for patients without other ocular comorbidity. Conclusion:? With adequate attention to detail, DSEK seems to be a safe and successful treatment for corneal endothelial disease, also during the surgeon��s learning curve. An alternative to penetrating keratoplasty (PK) for corneal endothelial disease has been sought by corneal surgeons for many years.